BAYZF - Bayer-back Boundless Bio sets terms for $100M IPO March, 21 2024 12:53 PM Bayer AG Registered Shares 2024-03-21 12:53:07 ET More on Boundless Bio, Inc. Boundless Bio Starts $100 Million U.S. IPO Plan IPO Roundup: Boundless Bio, NeOnc Technologies and more Oncology drug developer Boundless Bio files for $100M IPO Financial information for Boundless Bio, Inc. For further details see: Bayer-back Boundless Bio sets terms for $100M IPO